« Back
Home /
Anti-Rituximab Antibody (AY36) (recommended for ADA assay)

Anti-Rituximab Antibody (AY36) (recommended for ADA assay)

Item no.	RIB-Y36-100ug
Manufacturer	ACROBiosystems
Amount	100 ug
Category	Antibodies Primary Antibodies
Type	Antibody Primary
Format	Powder
Specific against	Mouse
Conjugate/Tag	Unconjugated
Purity	95%
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Available
Manufacturers Category	Antibody / Anti-idiotypic Antibodies
Description	Anti-Rituximab Antibodies (recommended for ADA assay) antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Rituximab.
Molecule	Rituximab
Manufacturers Host	Hybridoma
Storage	-20℃
Shipping	RT
Stability	4-8°C for 12 months in lyophilized state; -70°C for 12 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower. Please avoid repeated freeze-thaw cycles.
Buffer	Tris with Glycine, Arginine and NaCl, pH7.5
Background	Rituxan is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light- and heavy-chain variable region sequences and human constant region sequences. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 ug

available

Delivery expected until 8/16/2024